Acorah Software Products - Accounts Production 16.7.461 false true false true No description of principal activity 4 March 2024 31 March 2025 31 March 2025 15539084 Mr Muhammad Ahmad Mr Hemin Abdulrahman iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15539084 2024-03-03 15539084 2025-03-31 15539084 2024-03-04 2025-03-31 15539084 frs-core:CurrentFinancialInstruments 2025-03-31 15539084 frs-bus:PrivateLimitedCompanyLtd 2024-03-04 2025-03-31 15539084 frs-bus:FilletedAccounts 2024-03-04 2025-03-31 15539084 frs-bus:Micro-entities 2024-03-04 2025-03-31 15539084 frs-bus:AuditExempt-NoAccountantsReport 2024-03-04 2025-03-31 15539084 frs-bus:Director1 2024-03-04 2025-03-31 15539084 frs-bus:CompanySecretary1 2024-03-04 2025-03-31
Registered number: 15539084
Primecare Pharma Services Ltd
Unaudited Financial Statements
For the Period 4 March 2024 to 31 March 2025
Balance Sheet
Registered number: 15539084
31 March 2025
£
Fixed assets 3,705
Current assets 8,699
Creditors: Amounts Falling Due Within One Year (6,138 )
NET CURRENT ASSETS 2,561
TOTAL ASSETS LESS CURRENT LIABILITIES 6,266
Accruals and deferred income (299 )
NET ASSETS 5,967
CAPITAL AND RESERVES 5,967

Notes

1. General Information
Primecare Pharma Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15539084 . The registered office is Unit A, 82 James Carter Road, Mildenhall, IP28 7DE.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Muhammad Ahmad
Director
2nd December 2025